Mary Van Doren
Mary Van Doren, Executive Editorial Director at Dark Intelligence Group partner Mequoda Group, serves as DIG’s online editor. She optimizes DIG content for the Internet to ensure that it reaches the widest possible audience.
Mary’s experience includes writing search-optimized marketing copy both for Mequoda and for Mequoda clients, including the The Dark Intelligence Group, and directly tutoring clients in SEO content marketing. She has more than three decades of experience in both marketing and journalism. Just prior to joining Mequoda Group in 2012, she spent five years as Chief Copywriter for Elsevier Business Intelligence, where she helped promote publications, databases and conferences for C-suite executives in biopharma, medical devices and diagnostics.
Articles by Mary Van Doren
JAMA Study: Pathology field loses almost 18% Since 2007
This is a synopsis of two articles in the June 10, 2019 issue of THE DARK REPORT (TDR). The full articles are available to members of The Dark Intelligence Group. CEO SUMMARY: The number of professionals working in the pathology field in the United States declined by 17.53% from 2007 t…
TriCore Finds Value-Based Healthcare a Profitable Endeavor
This is an excerpt from a 3,380-word article in the May 20, 2019 issue of THE DARK REPORT. The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: To develop new sources of revenue to offset declining …
New UnitedHealthCare Preferred Lab Network Launches July 1
This is an excerpt from a 1,900-word article in the April 29, 2019 issue of THE DARK REPORT. The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: A new UnitedHealthCare (UHC) preferred lab network will launch July 1 with seven lab companies. In an April…
Ultimate Clinical Lab Automation: WakeMed Uses Drone to Deliver Patient Specimens
This is an excerpt from a 1,550-word article in the April 8, 2019 issue of THE DARK REPORT. The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: For two years, clinical lab professionals at WakeMed Health and Hospitals have tested the use of aerial dron…
Best Ways to Gather, Access, Report PAMA Lab Test Price Data to CMS
This is an excerpt from a 2,900-word article in the March 18, 2019 issue of THE DARK REPORT. The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: This is the first lab industry intelligence briefing which presents the lessons learned by a hospital syste…
PAMA Price Cuts Reduce Revenue at Two National Labs
This is an excerpt from a 1,500-word article in the Feb. 25, 2019 issue of THE DARK REPORT. The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: In their respective earnings reports for the fourth quarter and the full year of 2018, executives at both La…
Critical Lessons for Labs That Report PAMA Medicare Data
This is an excerpt from a 1,565-word article in the Feb.4 issue of THE DARK REPORT. The full article is available to paid members of The Dark Intelligence Group. CEO SUMMARY: With most hospitals now included as “applicable laboratories” in the PA…
Is There a Future for Hospital Lab Outreach Programs?
CEO SUMMARY: This will be one of the most challenging years facing the clinical lab industry since the early 1990s. The CMS scheme to collect private payer lab test prices and use that data to set Medicare clinical laboratory test pric…
2019 Outlook: Lab Industry Future Looks Dire, From Reactions to Recent Medicare Fraud Cases to PAMA Reporting and Other Stress Factors
CEO SUMMARY: This year’s list of the Top 10 Lab Industry Stories for 2018 is dominated by new directives from Medicare and private health insurers, as well as significant decisions by federal courts. Collectively, these developments create new compliance risks for all clinical laborator…
New Opioid Law Goes Beyond – Far Beyond – Anti-Kickback Statute
CEO SUMMARY: At the last minute, Congress added all clinical laboratories to a far-reaching provision in the newly-enacted …
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.